US EditionMusk slams New York Times after report on alleged drug use
- Elon Musk ended his role as head of the Department of Government Efficiency in a Friday Oval Office press conference with President Donald Trump where he dodged questions about alleged drug use.
- A report released on Friday accused Musk of regularly using ketamine, ecstasy, and mushrooms during his 2024 campaign efforts, claims that Musk has firmly denied.
- During the event, Musk interrupted a question about the report, cited past false reporting by the Times, and showed a black eye he said came from playing with his son, X.
- Musk stated on X, "To be clear, I am NOT taking drugs!" and called the Times report a lie, while Trump said he was unaware of any drug use and praised Musk.
- Musk's departure may reduce wasteful spending as he suggested his mission at DOGE will continue influencing government and he hopes to remain a Trump adviser.
205 Articles
205 Articles
Fox News Host Slams Musk for Dodging Drug Use Question
Fox News host Howard Kurtz has called out Elon Musk for deflecting questions about his alleged drug use while serving in the White House. The New York Times published a bombshell report this week on Musk’s alleged drug habits when he was President Donald Trump’s senior adviser at the Department of Government Efficiency (DOGE), which reportedly included taking magic mushrooms, ecstasy, Adderall, and enough ketamine to cause bladder issues. Musk w…
Elon Musk Responds To Claims He’s Using The Drug Ketamine * 100PercentFedUp.com * by Anthony T
Elon Musk is firing back at claims about his alleged ketamine use during his time in the White House. Discover his surprising response and the details behind the controversy that has everyone talking. Don’t miss out!
Elon Musk 'took large amounts of drugs including ketamine daily while advising Donald Trump'
Elon Musk is said to have used ketamine on an almost daily basis and mixing it with other narcotics whilst serving as a central figure in the Trump White House, sources close to him have claimed
Coverage Details
Bias Distribution
- 35% of the sources lean Right
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
